Venovenous extracorporeal membrane oxygenation for patients with refractory coronavirus disease 2019 (COVID-19): Multicenter experience of referral hospitals in a large health care system

The Journal of Thoracic and Cardiovascular Surgery

article

Emily Shih¹  J. Michael DiMaio²  John J. Squiers¹  Jasjit K. Banwait³  Dan M. Meyer⁴  Timothy J. George²  Gary S. Schwartz⁴ 

[1] Department of General Surgery, Baylor University Medical Center;Department of Cardiothoracic Surgery, Baylor Scott and White The Heart Hospitals;Baylor Scott and White Research Institute;Department of Cardiothoracic Surgery, Baylor University Medical Center

关键词: coronavirus (COVID-19);    acute respiratory distress syndrome (ARDS);    extracorporeal membrane oxygenation (ECMO);    critical care;   

DOI  :  10.1016/j.jtcvs.2020.11.073

学科分类：心脏病和心血管学

来源: Mosby, Inc.

【 摘 要 】

The benefit of extracorporeal membrane oxygenation (ECMO) for patients with severe acute respiratory distress from coronavirus disease 2019 refractory to medical management and lung-protective mechanical ventilation has not been adequately determined.

【 授权许可】

Unknown